You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Iberdomide

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • Iberdomide
  • Daratumumab/rHuPH20 Co-formulation
  • (no location specified)
Oct 25, 2023

Healthy Volunteers Trial in Daytona Beach (Iberdomide)

Recruiting
  • Healthy Volunteers
  • Iberdomide
  • Daytona Beach, Florida
    Labcorp Clinical Research Unit, Inc. - Daytona Beach
Jun 9, 2023

Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Iberdomide
  • +6 more
  • Miami, Florida
    University of Miami
May 31, 2023

Multiple Myeloma Trial in New York (Iberdomide, Elotuzumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Iberdomide
  • +2 more
  • New York, New York
    Icahn School of Medicine
Jan 20, 2023

Iberdomide and Mezigdomide in Healthy Participants

Not yet recruiting
  • Healthy Participants
    • (no location specified)
    Sep 12, 2022

    Renal Insufficiency Trial in Orlando, Knoxville, San Antonio (Iberdomide)

    Recruiting
    • Renal Insufficiency
    • Iberdomide
    • Orlando, Florida
    • +5 more
    Dec 16, 2022

    Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • Iberdomide
    • +2 more
    • (no location specified)
    Jul 18, 2022

    Multiple Myeloma Trial in Omaha (Iberdomide)

    Recruiting
    • Multiple Myeloma
    • Iberdomide
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Apr 27, 2022

    Multiple Myeloma Trial in Worldwide (Iberdomide)

    Recruiting
    • Multiple Myeloma
    • Iberdomide
    • Nantes, France
    • +3 more
    Aug 16, 2022

    Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

    Recruiting
    • Plasma Cell Myeloma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Multiple Myeloma Trial in United States (Iberdomide, Daratumumab, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma
    • Iberdomide
    • +3 more
    • Durham, North Carolina
    • +5 more
    Jun 22, 2022

    Multiple Myeloma Trial in Belgium, France, United States (EOS884448, Iberdomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Hackensack, New Jersey
    • +3 more
    Jun 15, 2022

    Multiple Myeloma Trial in United States (Iberdomide)

    Recruiting
    • Multiple Myeloma
    • Iberdomide
    • Basking Ridge, New Jersey
    • +7 more
    Jun 10, 2022

    Multiple Myeloma Trial in Netherlands (Iberdomide plus low-dose cyclophosphamide and dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Iberdomide plus low-dose cyclophosphamide and dexamethasone
    • Alkmaar, Netherlands
    • +8 more
    Oct 5, 2021

    Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

    Not yet recruiting
    • Multiple Myeloma
    • Boston, Massachusetts
    • +1 more
    Nov 2, 2023

    Multiple Myeloma at First Relapse Trial in France (Ixazomib, Iberdomide, Dexamethasone Oral)

    Recruiting
    • Multiple Myeloma at First Relapse
    • Annecy, France
    • +20 more
    Dec 16, 2021

    Lymphoma, B-Cell Trial in Worldwide (CC-220, Rituximab, Cyclophosphamide)

    Recruiting
    • Lymphoma, B-Cell
    • Scottsdale, Arizona
    • +26 more
    Jul 1, 2022

    Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)

    Not yet recruiting
    • Newly Diagnosed Multiple Myeloma
    • Alcalá de Henares, Madrid, Spain
    • +67 more
    Sep 23, 2022

    Lymphoma, B-Cell Trial in Worldwide (CC-220, Polatuzumab vedotin, Rituximab)

    Withdrawn
    • Lymphoma, B-Cell
    • Boston, Massachusetts
    • +26 more
    Sep 28, 2021

    Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

    Recruiting
    • Multiple Myeloma
    • Orlando, Florida
    • +240 more
    Aug 18, 2022

    Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Orange, California
    • +270 more
    Apr 11, 2023

    Lymphoma Trial in Worldwide (CC-220, Rituximab, Obinutuzumab)

    Recruiting
    • Lymphoma
    • Phoenix, Arizona
    • +36 more
    Jul 28, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • JCAR017
    • +7 more
    • Duarte, California
    • +17 more
    Jan 13, 2023

    Multiple Myeloma Trial in France (Isatuximab, ASCT)

    Recruiting
    • Multiple Myeloma
    • AMIENS Cedex 1, France
    • +67 more
    Mar 28, 2022

    Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

    Recruiting
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +126 more
    Jan 10, 2023